Government nutritional review findings echo dementia risk messaging

Alzheimer’s Research UK is backing the findings of a Scientific Advisory Committee on Nutrition (SACN) review on diet and its impact on cognitive impairment and dementia. The committee has published a report that finds there...

Genetic tool to predict adult heart attack risk in childhood

Powerful technology paves way for early interventions to prevent heart attacks. People at high risk of a heart attack in adulthood could be spotted much earlier in life with a one-off DNA test, according to...

New Jurassic flying reptile has the oldest opposed thumb

A new 160-million-year-old arboreal pterosaur species, dubbed ‘Monkeydactyl’, has the oldest true opposed thumb - a novel structure previously not known in pterosaurs. An international team of researchers from China, Brazil, UK, Denmark and Japan...

Ayrshire Life Science Company launch advanced scientific technology to support successful drug development

AvantiCell Science is a life science company based in Ayr, with a mission to provide leading-edge ethical tools which offer the prospect of faster, more efficient progress towards better drugs, safer chemotherapy, and improved...

Find out why County Durham’s NETPark is quickly becoming a global hub for bio-science...

Home to two UK catapult centres, three national innovation centres and one of the country’s leading AIM listed tech companies, The North East Technology Park (NETPark) really is a thriving hub of innovation making...

The time for stents is here

The use of stents to keep neck arteries open is just as effective as invasive neck surgery for long-term prevention of fatal and disabling strokes, according to an  international trial. Now, the team says that...

Firms call for major R&I investment to tackle environmental crises

Major investment into research and innovation (R&I) is needed to enable UK businesses to address the global biodiversity and climate crises, according to a new report. The report by the Valuing Nature Programme --– which...

Research ‘must be allowed to thrive’

The Parkinson’s Disease Society has embarked on a new drive to ensure that research into the illness, and other conditions, continues to be supported across Europe. As part of the campaign, which is hosted by...

Aspirin could reduce cancer risk

Research has shown that a regular dose of aspirin reduces the long-term risk of cancer in this who are overweight. The findings came out of an international study of people with a family history of...

Calcium may play a role in the development of Parkinson’s disease

Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson’s disease. This is the first time we’ve seen that calcium...

Life sciences – what’s the big deal?

People often ask me why life sciences are so important. For me, important things are those which have a clear impact on the future. Things to be addressed now rather than later. Things such as...

Ayrshire Life Science Company Launch Advanced Scientific Technology to Support Successful Drug Development

AvantiCell Science is a life science company based in Ayr, with a mission to provide leading-edge ethical tools which offer the prospect of faster, more efficient progress towards better drugs, safer chemotherapy, and improved...

CRC celebrates 50 years in cleanroom design and build

Clean Room Construction is celebrating 50 years of cleanroom design and build success in 2017. The Kent-based company has grown to become one of the UK’s leading cleanroom design and build specialists for blue chip...

Cracking the code could be key to tackling infections

Researchers have made a major breakthrough in tackling infections caused by a major group of viruses including the common cold and polio. The team has cracked a code hidden in the sequence of the ribonucleic...

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

Next Generation ADC Uses Proprietary Technologies Aimed at Enhancing Cancer Therapy Efficacy and Safety Nijmegen, The Netherlands – 11 August 2020 – Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first cancer patients...

Results of MDMA treatment trial for alcohol use disorder published

Awakn Life Sciences Inc. announces today the publication of results from its CMO Dr. Ben Sessa’s Bristol Imperial MDMA in Alcoholism (BIMA) trial, an open-label safety, tolerability and proof-of-concept study investigating the potential role...